EyePoint Pharmaceuticals ... (EYPT)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

7.96

6.49%

After-hours Dec 13, 2024, 05:55 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03
Net Income	-70.80M	-102.25M	-58.42M	-45.39M	-56.79M	-53.17M	-18.48M	-21.55M	6.35M	-13.36M	-11.90M	-24.84M	-8.63M	8.75M	-2.51M	-75.67M	-103.67M	-20.91M	-11.49M	-5.22M	-3.60M
Depreciation & Amortization	464.00K	2.45M	2.77M	2.65M	2.60M	1.15M	815.00K	908.00K	882.00K	917.00K	994.00K	2.23M	3.35M	3.33M	3.44M	397.00K	8.72M	8.70M	1.24M	240.94K	212.09K
Stock-Based Compensation	12.06M	14.18M	7.45M	5.55M	4.57M	3.97M	2.70M	2.46M	2.16M	1.96M	1.41M	1.32M	1.41M	2.05M	1.50M	-	-	-	-	-	-
Other Working Capital	44.48M	-799.00K	-959.00K	16.62M	31.00K	-70.00K	-106.00K	108.00K	-76.00K	-230.00K	35.00K	-1.90M	880.00K	-3.53M	-8.30M	-	-	-	-	-	-
Other Non-Cash Items	1.18M	23.65M	628.00K	1.72M	1.65M	209.00K	-5.59M	87.00K	98.00K	45.00K	152.00K	14.92M	-951.00K	339.00K	311.00K	57.22M	92.29M	1.45M	1.24M	-1.02M	67.18K
Deferred Income Tax	83.00K	-	-787.00K	905.00K	3.81M	26.28M	-	-	-	-78.00K	-	-13.00K	-209.00K	1K	-94.00K	-535.00K	-23.53M	-7.07M	-	-	-
Change in Working Capital	58.88M	-3.02M	-1.74M	20.14M	-12.54M	925.00K	318.00K	2.07M	1.01M	389.00K	692.00K	-2.71M	1.21M	-4.01M	-10.45M	13.46M	147.00K	2.19M	-339.07K	564.36K	259.15K
Operating Cash Flow	1.88M	-65.00M	-50.10M	-14.44M	-56.70M	-21.91M	-20.49M	-16.32M	10.30M	-10.67M	-8.74M	-9.00M	-3.17M	9.90M	-8.44M	-5.14M	-21.21M	-16.14M	-9.34M	-5.44M	-3.06M
Capital Expenditures	-3.48M	-2.15M	-156.00K	-362.00K	-213.00K	-108.00K	-147.00K	-113.00K	-161.00K	-248.00K	-68.00K	-405.00K	-133.00K	-15.00K	-195.00K	-272.00K	-82.00K	-1.15M	-2.59M	-366.33K	-35.58K
Acquisitions	-168.00K	-558.00K	-	-	-	-16.78M	-16.78M	33.00K	-	78.00K	-	-	-	-	-	-	1.85M	-2.99M	-4.03B	-	-418.30K
Purchase of Investments	-55.12M	-139.12M	-32.97M	-	-	-	-5.05M	-17.52M	-10.22M	-2.96M	-7.76M	-15.39M	-15.96M	-2.05M	-2.05M	-	-	-	-	-	-
Sales Maturities Of Investments	55.28M	124.00M	-	-	-	-	18.74M	13.17M	3.65M	3.35M	14.18M	16.40M	6.60M	6.60M	-	-	-	-	-	-	-
Other Investing Acitivies	168.00K	558.00K	-32.97M	-	-	-	33.00K	13.72M	-4.35M	-150.00K	314.00K	6.43M	1.01M	-	-	13.00K	-	19.24K	-3.53M	-	418.98K
Investing Cash Flow	-3.31M	-17.27M	-33.12M	-362.00K	-213.00K	-16.89M	13.58M	-4.46M	-6.73M	66.00K	6.36M	606.00K	-9.50M	-2.07M	-195.00K	-259.00K	1.77M	-4.13M	-6.12M	-366.33K	-34.90K
Debt Repayment	-40.51M	2.10M	-146.00K	-11.80M	30.00M	20.00M	20.00M	-	-	-	-	-	-	-	-	-	-	-13.34M	14.44M	-	-
Common Stock Repurchased	-	-295.00K	-	-	-	-195.00K	-	-	-	-	-	-	-	-	-	-	-2.24M	-	-	-	-
Dividend Paid	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Financial Acitivies	1.41M	-2.50M	223.00K	-624.00K	-18.76M	-20.20M	-844.00K	99.00K	490.00K	235.00K	987.00K	-	114.00K	17.00K	802.00K	18.39M	-	7.51M	-1.66M	-20.82K	310.50K
Financial Cash Flow	187.07M	-690.00K	216.90M	37.49M	33.86M	60.67M	8.50M	16.99M	235.00K	19.04M	4.67M	114.00K	10.06M	802.00K	802.00K	18.39M	10.13M	21.65M	2.76M	25.68M	572.75K
Net Cash Flow	185.63M	-82.96M	133.68M	22.70M	-23.05M	21.88M	1.58M	-3.81M	3.79M	8.44M	2.27M	-8.29M	-2.60M	8.62M	-8.71M	12.94M	-10.43M	1.90M	-14.02M	20.97M	-2.60M
Free Cash Flow	-1.61M	-67.16M	-50.25M	-14.80M	-56.91M	-22.02M	-20.64M	-16.43M	10.14M	-10.92M	-8.81M	-9.41M	-3.30M	9.88M	-8.63M	-5.42M	-21.30M	-17.29M	-11.93M	-5.80M	-3.10M